BioCatalystWatch
AXSMWorkspace / AXSM / OverviewCompany library

Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc. (AXSM)

Price
Market cap
Next catalystExpected Q1 2027SUNOSI (solriamfetol) — ENGAGE and separate BED long-term study · Phase 3 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

AXS-12 (reboxetine)

PreINDP1P2P3FilingApproved
Upcoming / outlook

AXS-20 (balipodect)

PDE10A

PreINDP1P2FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

AXS-20 (balipodect)

PDE10A

PreINDP1P2FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

AXS-12 (reboxetine)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

AXS-17

GABAA receptor α2/α3

PreINDP2P3FilingApproved
Upcoming / outlook

SUNOSI (solriamfetol)

TAAR1 × 5-HT1A

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

AUVELITY (AXS-05)

NMDA receptor × Sigma-1 receptor × CYP2D6

PreINDP1P2P3FilingApproved

Approved / commercial

SUNOSI (solriamfetol)

TAAR1 × 5-HT1A

Approved

PreINDP1P2P3FilingApproved

COX-2 × 5-HT1B/1D receptor

Approved

PreINDP1P2P3FilingApproved
AUVELITY (AXS-05)

NMDA receptor × Sigma-1 receptor × CYP2D6

Approved

PreINDP1P2P3FilingApproved
AUVELITY (AXS-05)

NMDA receptor × Sigma-1 receptor × CYP2D6

Approved

PreINDP1P2P3FilingApproved

History / paused

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

AXSM PR & News

PR & News

AXSM SEC archive